Mobile

By HIMSS TV 08:07 am January 15, 2020
Muse founder Ariel Garten describes how the company's headband technology offers a clinical-grade EEG that tracks brain waves during meditation and how mind-body medicine is gaining appreciation on the provider side.
By HIMSS TV 05:00 pm December 31, 2019
Rashmi Patel, Fulbright Scholar at Beth Israel Deaconess Medical Center, says active monitoring can ask questions while sensors can go deeper into mood and anxiety levels.
By HIMSS TV 05:00 pm December 23, 2019
Technology adoption is revamping personal health education and support, says Malinda Peeples, VP of clinical services, programs and research at WellDoc. 
Sponsored
By 11:04 am October 30, 2019
Anders Strömberg, head of the wearable platform department at Sony, says the company's new B2B mSafety platform features a smartwatch with built-in sensors, a simple user interface, a secure back end and long battery life.
By HIMSS TV 07:59 pm October 24, 2019
Biorithm co-founder and CEO Amrish Nair describes how his company's sensors take care out of the hospital to wherever the expectant mom is.
By HIMSS TV 08:35 am October 18, 2019
With its smart sharps bin, HealthBeacon is going deep on one important medication adherence use case: self-administered injectables, says CEO Jim Joyce.
By HIMSS TV 07:39 am October 16, 2019
Wellysis' device can provide data to can help patients and doctors make better healthcare decisions, says co-founder and CEO Young Juhn.
By HIMSS TV 04:45 pm October 15, 2019
Aakash Ganju, MD, CEO of Saathealth, says consumers from all over the world are used to choice and autonomy on their phones, and there's an opportunity to apply that mindset to managing healthcare.
By HIMSS TV 08:05 am September 25, 2019
Vizlitics' bi-directional engagement platform aims to improve the clinical experience for patients and physicians alike, says CEO Tarun Kumar.
By HIMSS TV 11:50 am September 19, 2019
Health 2.0 VentureConnect winner Sana Health's wearable therapeutic device uses pulsed light and sound to reduce pain and potentially treat neurological conditions, says CEO Richard Hanbury.

Most Read

The Daily Brief Newsletter